Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Non-Current Assets (2016 - 2026)

Ekso Bionics Holdings has reported Non-Current Assets over the past 13 years, most recently at $6.1 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 22.37% to $6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.4 million, a 16.41% decrease, with the full-year FY2025 number at $6.1 million, down 22.37% from a year prior.
  • Non-Current Assets reached $6.1 million in Q4 2025 per EKSO's latest filing, down from $6.9 million in the prior quarter.
  • The five-year high for Non-Current Assets was $9.9 million in Q4 2022, with the low at $1.1 million in Q1 2022.
  • The 5-year median for Non-Current Assets is $7.2 million (2025), against an average of $5.9 million.
  • Peak YoY movement for Non-Current Assets: plummeted 41.07% in 2022, then surged 749.6% in 2023.
  • Tracing EKSO's Non-Current Assets over 5 years: stood at $1.4 million in 2021, then surged by 619.62% to $9.9 million in 2022, then decreased by 11.72% to $8.7 million in 2023, then fell by 10.34% to $7.8 million in 2024, then fell by 22.37% to $6.1 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $6.1 million, $6.9 million, and $7.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.